UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure
September 23, 2016 at 07:12 AM EDT
ZURICH, Sept 23 (Reuters) - Novartis's Zykadia drug performed well against a rare form of lung cancer, the Swiss company said on Friday, citing a study it hopes will help it win expanded regulatory approval for the use of the drug.
